Cargando…

Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species

BACKGROUND: Cost-effectiveness studies of echinocandins for the treatment of invasive candidiasis, including candidemia, are rare in Asia. No study has determined whether echinocandins are cost-effective for both Candida albicans and non-albicans Candida species. There have been no economic evaluati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ou, Huang-Tz, Lee, Tsung-Ying, Chen, Yee-Chun, Charbonneau, Claudie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504557/ https://www.ncbi.nlm.nih.gov/pubmed/28693479 http://dx.doi.org/10.1186/s12879-017-2573-8

Ejemplares similares

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017)

Low prevalence of antifungal resistant Candida africana, in the C. albicans complex causing vulvovaginal candidiasis
por: Farahyar, Shirin, et al.
Publicado: (2020)

Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species
por: Cheng, Ming-Fang, et al.
Publicado: (2005)

Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal Candida albicans and Non-Candida albicans Species
por: Mohammadi, Faezeh, et al.
Publicado: (2021)

Molecular Identification and Antifungal Susceptibility Pattern of Non-albicans Candida Species Isolated from Vulvovaginal Candidiasis
por: Nejat, Ziba Abbasi, et al.
Publicado: (2018)

Neutrophils From Patients With Invasive Candidiasis Are Inhibited by Candida albicans Biofilms
por: Kernien, John F., et al.
Publicado: (2020)

Multi-species biofilm of Candida albicans and non-Candida albicans Candida species on acrylic substrate
por: K PATHAK, Apurva, et al.
Publicado: (2012)

Genotyping, antifungal susceptibility, enzymatic activity, and phenotypic variation in Candida albicans from esophageal candidiasis
por: Jafarian, Hadis, et al.
Publicado: (2021)

Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
por: Mandras, Narcisa, et al.
Publicado: (2016)

Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia
por: Seyoum, Elias, et al.
Publicado: (2020)

Incidence and Antifungal Susceptibility of Candida Albicans Infections
por: UNGUREANU, A., et al.
Publicado: (2016)

Glycogen Metabolism in Candida albicans Impacts Fitness and Virulence during Vulvovaginal and Invasive Candidiasis
por: Miao, Jian, et al.
Publicado: (2023)

Candida glabrata Binding to Candida albicans Hyphae Enables Its Development in Oropharyngeal Candidiasis
por: Tati, Swetha, et al.
Publicado: (2016)

Mucosal Bacteria Modulate Candida albicans Virulence in Oropharyngeal Candidiasis
por: Bertolini, M., et al.
Publicado: (2021)

Cation Transporters of Candida albicans—New Targets to Fight Candidiasis?
por: Volkova, Marina, et al.
Publicado: (2021)

The Bovhyaluronidase Azoximer (Longidaza(®)) Disrupts Candida albicans and Candida albicans-Bacterial Mixed Biofilms and Increases the Efficacy of Antifungals
por: Gatina, Alina, et al.
Publicado: (2022)

Factor associated with oral candidiasis caused by co-infection of Candida albicans and Candida glabrata: A retrospective study
por: Hato, Hiroyuki, et al.
Publicado: (2022)

Differences in Ocular Complications Between Candida albicans and Non-albicans Candida Infection Analyzed by Epidemiology and a Mouse Ocular Candidiasis Model
por: Abe, Masahiro, et al.
Publicado: (2018)

Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans
por: Victorio, Gerardo Becerra, et al.
Publicado: (2017)

Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis
por: Xin, Hong, et al.
Publicado: (2023)

Potent Antifungal Activity of Penta-O-galloyl-β-d-Glucose against Drug-Resistant Candida albicans, Candida auris, and Other Non-albicans Candida Species
por: Marquez, Lewis, et al.
Publicado: (2023)

Successful Treatment of Chronic Mucocutaneous Candidiasis Caused by Azole-Resistant Candida albicans with Posaconazole
por: Firinu, Davide, et al.
Publicado: (2011)

In Vitro Antifungal Activity of Equol against Candida albicans
por: Lee, Jeong Ah, et al.
Publicado: (2010)

Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles
por: Shinde, Ravikumar Bapurao, et al.
Publicado: (2013)

Frequency of Candidiasis and Colonization of Candida albicans in Relation to Oral Contraceptive Pills
por: Aminzadeh, Atousa, et al.
Publicado: (2016)

Molecular association of Candida albicans and vulvovaginal candidiasis: focusing on a solution
por: David, Helma, et al.
Publicado: (2023)

Clinical Features and Outcomes of Persistent Candidemia Caused by Candida albicans versus Non-albicans Candida Species: A Focus on Antifungal Resistance and Follow-Up Blood Cultures
por: Kitaya, Shiori, et al.
Publicado: (2023)

How does temperature trigger biofilm adhesion and growth in Candida albicans and two non‐Candida albicans Candida species?
por: Casagrande Pierantoni, Debora, et al.
Publicado: (2021)

Antifungal and Antibiofilm Activity of Cyclic Temporin L Peptide Analogues against Albicans and Non-Albicans Candida Species
por: Bellavita, Rosa, et al.
Publicado: (2022)

WMR Peptide as Antifungal and Antibiofilm against Albicans and Non-Albicans Candida Species: Shreds of Evidence on the Mechanism of Action
por: Maione, Angela, et al.
Publicado: (2022)

Exploring the Antifungal Activity and Action of Saussurea costus Root Extracts against Candida albicans and Non-albicans Species
por: Soliman, Melad F., et al.
Publicado: (2022)

Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients
por: Wu, Ping-Feng, et al.
Publicado: (2017)

Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis
por: Tamai, Iradj Ashrafi, et al.
Publicado: (2021)

Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
por: Ishida, Kelly, et al.
Publicado: (2011)

In vitro antifungal potency of the moronecidin-like peptide against Candida albicans, Candida glabrata, and Candida tropicalis
por: Amirrajab, Nasrin, et al.
Publicado: (2023)

2447. Clinical Features and Outcome of Persistent Candidemia Caused by Candida albicans versus Non-albicans Candida Species: A Focus on Antifungal Resistance and Follow-up Blood Cultures
por: Kitaya, Shiori, et al.
Publicado: (2023)

Filamentous Non-albicans Candida Species Adhere to Candida albicans and Benefit From Dual Biofilm Growth
por: Pathirana, Ruvini U., et al.
Publicado: (2019)

Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
por: Rhimi, Wafa, et al.
Publicado: (2020)

Cutaneous candidiasis caused by Candida albicans in a young non-immunosuppressed patient: an unusual presentation
por: Palese, Enzo, et al.
Publicado: (2018)

Artemisinins inhibit oral candidiasis caused by Candida albicans through the repression on its hyphal development
por: Liang, Xiaoyue, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7n7gbja9rs1ie21sj6vapd4pg7